-+ 0.00%
-+ 0.00%
-+ 0.00%

Pharma Equity Group Leads 3 European Penny Stocks

Simply Wall St·07/20/2026 10:04:53
语音播报

The European market has recently experienced a mixed performance, with the pan-European STOXX Europe 600 Index ending a volatile week nearly unchanged amid global tech weakness and geopolitical tensions. Despite these challenges, investors continue to explore opportunities within smaller or newer companies, often referred to as penny stocks. Although the term may seem outdated, these stocks can still offer significant value when backed by solid financials and potential for growth.

Let's explore several standout options from the results in the screener.

Pharma Equity Group (CPSE:PEG)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Pharma Equity Group A/S, with a market cap of DKK105.57 million, operates through its subsidiary Reponex Pharmaceuticals A/S to develop treatments for impactful diseases where current therapies are inadequate.

Operations: No revenue segments have been reported for Pharma Equity Group A/S.

Market Cap: DKK105.57M

Pharma Equity Group A/S, with a market cap of DKK105.57 million, is pre-revenue and operates through Reponex Pharmaceuticals A/S. The company recently raised DKK 9.63 million through a private placement of convertible loans, which can be converted into shares at a later date, potentially affecting share capital by up to DKK 12.70 million. Despite having short-term assets exceeding both short and long-term liabilities, the company faces high volatility and zero cash runway based on free cash flow estimates before the recent capital raise. Its net debt to equity ratio is satisfactory but remains unprofitable with negative return on equity.

CPSE:PEG Financial Position Analysis as at Jul 2026
CPSE:PEG Financial Position Analysis as at Jul 2026

Pearl Gold (DB:02P)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Pearl Gold AG is a holding company that invests in gold mining projects across Africa and has a market capitalization of €12.50 million.

Operations: No revenue segments are reported for this holding company that focuses on gold mining projects in Africa.

Market Cap: €12.5M

Pearl Gold AG, with a market cap of €12.50 million, is pre-revenue and focuses on gold mining projects in Africa. The company is debt-free, which alleviates concerns about interest coverage and cash flow requirements for debt servicing. Despite having short-term assets of €8.2 million that exceed both its short-term liabilities (€106K) and long-term liabilities (€1.1M), Pearl Gold remains unprofitable with increasing losses over the past five years at a rate of 75.7% per year. Its share price has been highly volatile recently, though shareholder dilution has not been significant in the past year.

DB:02P Financial Position Analysis as at Jul 2026
DB:02P Financial Position Analysis as at Jul 2026

Nurminen Logistics Oyj (HLSE:NLG1V)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Nurminen Logistics Oyj offers logistics services across Finland, Sweden, and the Baltic countries, with a market cap of €56.52 million.

Operations: The company's revenue from the Transportation - Trucking segment amounts to €102.50 million.

Market Cap: €56.52M

Nurminen Logistics Oyj, with a market cap of €56.52 million, operates in the logistics sector across Finland, Sweden, and the Baltic countries. The company has experienced negative earnings growth recently but maintains a satisfactory net debt to equity ratio of 21.5%. Its short-term assets exceed both short and long-term liabilities, indicating sound financial health despite recent challenges like a large one-off loss impacting earnings. While its return on equity is low at 11.1%, Nurminen's debt is well covered by operating cash flow (53%). Recent executive changes include appointing Mikko Kuusilehto as CEO from January 2027 to steer future growth strategies.

HLSE:NLG1V Revenue & Expenses Breakdown as at Jul 2026
HLSE:NLG1V Revenue & Expenses Breakdown as at Jul 2026

Taking Advantage

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.